Advanced viral gene therapy eradicates prostate cancer in preclinical experiments
Monday, May 11, 2015 - 09:50
in Health & Medicine
Even with the best available treatments, the median survival of patients with metastatic, hormone-refractory prostate cancer is only two to three years. Driven by the need for more effective therapies […]